| scholarly article | Q13442814 |
| P2093 | author name string | Xin Zhao | |
| Yu Liu | |||
| Haodong Lin | |||
| Jingdong Rao | |||
| Yuhe Yang | |||
| Ho Pan Bei | |||
| P2860 | cites work | Platelet activation after stenting with heparin-coated versus noncoated stents | Q28165719 |
| Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis | Q28263271 | ||
| Macromolecular approaches to prevent thrombosis and intimal hyperplasia following percutaneous coronary intervention | Q28654633 | ||
| Incidence of side-effects of dual antiplatelet therapy with clopidogrel and aspirin after coronary stent implantation | Q33410893 | ||
| Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for Glaucoma | Q33589704 | ||
| Improved Hemocompatibility of Multilumen Catheters via Nitric Oxide (NO) Release from S-Nitroso-N-acetylpenicillamine (SNAP) Composite Filled Lumen | Q33647184 | ||
| The attenuation of platelet and monocyte activation in a rabbit model of extracorporeal circulation by a nitric oxide releasing polymer | Q33648166 | ||
| eNOS transfection of adipose-derived stem cells yields bioactive nitric oxide production and improved results in vascular tissue engineering | Q33728866 | ||
| cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action | Q34244951 | ||
| Mechanisms of thrombus formation | Q34815800 | ||
| Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities | Q35058921 | ||
| Endothelial progenitor cells: mobilization, differentiation, and homing | Q35114634 | ||
| Breathing new life into nitric oxide signaling: A brief overview of the interplay between oxygen and nitric oxide | Q35757318 | ||
| eNOS at a glance | Q35782010 | ||
| Nitric oxide release: part II. Therapeutic applications | Q35926097 | ||
| Role of stent design and coatings on restenosis and thrombosis | Q36464949 | ||
| Novel Multifunctional Nanomatrix Reduces Inflammation in Dynamic Conditions in Vitro and Dilates Arteries ex Vivo | Q37527721 | ||
| Nitric oxide: a guardian for vascular grafts? | Q37887771 | ||
| Nitric oxide donors for cardiovascular implant applications | Q38058487 | ||
| Biased signaling of protease-activated receptors | Q38214613 | ||
| State of the art, challenges and perspectives in the design of nitric oxide-releasing polymeric nanomaterials for biomedical applications. | Q38338195 | ||
| Strategies to increase nitric oxide signalling in cardiovascular disease | Q38565004 | ||
| Role of oxidative stress on platelet hyperreactivity during aging. | Q38731638 | ||
| Nano-biomaterials for cardiovascular applications: Clinical perspective | Q38779053 | ||
| Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis. | Q39139744 | ||
| Contemporary Approaches to Modulating the Nitric Oxide-cGMP Pathway in Cardiovascular Disease | Q39209626 | ||
| Strategies to develop endogenous stem cell-recruiting bioactive materials for tissue repair and regeneration. | Q39452218 | ||
| Surface engineering of cardiovascular stent with endothelial cell selectivity for in vivo re-endothelialisation | Q39478673 | ||
| Transition-Metal-Mediated Release of Nitric Oxide (NO) from S-Nitroso-N-acetyl-d-penicillamine (SNAP): Potential Applications for Endogenous Release of NO at the Surface of Stents Via Corrosion Products | Q39875088 | ||
| Stent-based delivery of adeno-associated viral vectors with sustained vascular transduction and iNOS-mediated inhibition of in-stent restenosis | Q40074066 | ||
| Tunable Nitric Oxide Release from S-Nitroso-N-acetylpenicillamine via Catalytic Copper Nanoparticles for Biomedical Applications | Q40250896 | ||
| Full-course inhibition of biodegradation-induced inflammation in fibrous scaffold by loading enzyme-sensitive prodrug | Q41044467 | ||
| Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent f | Q42872756 | ||
| A nitric oxide releasing, self assembled peptide amphiphile matrix that mimics native endothelium for coating implantable cardiovascular devices | Q42926908 | ||
| Regulation of the expression of inducible nitric oxide synthase | Q43075744 | ||
| Delayed re-endothelialization with rapamycin-coated stents is rescued by the addition of a glycogen synthase kinase-3beta inhibitor | Q43157373 | ||
| Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. | Q45121029 | ||
| Polysaccharide-based biomaterials with on-demand nitric oxide releasing property regulated by enzyme catalysis | Q45410952 | ||
| Regulation of polyurethane hemocompatibility and endothelialization by tethered hyaluronic acid oligosaccharides. | Q45939743 | ||
| Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study | Q46056339 | ||
| Functional Layer-by-layer Thin Films of Inducible Nitric Oxide (NO) Synthase Oxygenase and Polyethylenimine: Modulation of Enzyme Loading and NO-Release Activity. | Q48527405 | ||
| Saving 100 million lives by improving global treatment of hypertension and reducing cardiovascular disease risk factors. | Q49690781 | ||
| Nitric Oxide Releasing Coronary Stent: A New Approach Using Layer-by-Layer Coating and Liposomal Encapsulation. | Q51165353 | ||
| Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. | Q51170005 | ||
| Bioresorbable Vascular Scaffolds: More Different Than Alike? | Q51418061 | ||
| Enzyme-functionalized vascular grafts catalyze in-situ release of nitric oxide from exogenous NO prodrug. | Q52941257 | ||
| Progress and Promise of Nitric Oxide-Releasing Platforms. | Q55285400 | ||
| Enzyme Prodrug Therapy Achieves Site-Specific, Personalized Physiological Responses to the Locally Produced Nitric Oxide. | Q55338911 | ||
| Pathology of Endovascular Stents. | Q64938119 | ||
| Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction | Q77836261 | ||
| Local delivery of nitric oxide from an eluting stent to inhibit neointimal thickening in a porcine coronary injury model | Q77996345 | ||
| Immobilization of selenocystamine on TiO2 surfaces for in situ catalytic generation of nitric oxide and potential application in intravascular stents | Q82532853 | ||
| Mussel-inspired immobilization of vascular endothelial growth factor (VEGF) for enhanced endothelialization of vascular grafts | Q84194645 | ||
| The effect of VEGF functionalization of titanium on endothelial cells in vitro | Q84985315 | ||
| Improved endothelialization and reduced thrombosis by coating a synthetic vascular graft with fibronectin and stem cell homing factor SDF-1α | Q85027875 | ||
| Tissue-engineered acellular small diameter long-bypass grafts with neointima-inducing activity | Q87243891 | ||
| Mussel-inspired catalytic selenocystamine-dopamine coatings for long-term generation of therapeutic gas on cardiovascular stents | Q89104338 | ||
| Zinc Oxide Particles Catalytically Generate Nitric Oxide from Endogenous and Exogenous Prodrugs | Q90103011 | ||
| Achieving Long-Term Biocompatible Silicone via Covalently Immobilized S-Nitroso- N-acetylpenicillamine (SNAP) That Exhibits 4 Months of Sustained Nitric Oxide Release | Q90365410 | ||
| Mussel-inspired dopamine-CuII coatings for sustained in situ generation of nitric oxide for prevention of stent thrombosis and restenosis | Q90778084 | ||
| Versatile biomimetic medical device surface: hydrophobin coated, nitric oxide-releasing polymer for antimicrobial and hemocompatible applications | Q91573797 | ||
| Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registry | Q92073058 | ||
| Nitric-Oxide-Releasing Biomaterial Regulation of the Stem Cell Microenvironment in Regenerative Medicine | Q92687174 | ||
| From surface to bulk modification: Plasma polymerization of amine-bearing coating by synergic strategy of biomolecule grafting and nitric oxide loading | Q92760406 | ||
| Multifunctional S-Nitroso-N-acetylpenicillamine-Incorporated Medical-Grade Polymer with Selenium Interface for Biomedical Applications | Q93098179 | ||
| Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study | Q93159663 | ||
| Endothelium-Mimicking Multifunctional Coating Modified Cardiovascular Stents via a Stepwise Metal-Catechol-(Amine) Surface Engineering Strategy | Q94673624 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 578 | |
| P577 | publication date | 2020-06-24 | |
| P1433 | published in | Frontiers in Bioengineering and Biotechnology | Q21971197 |
| P1476 | title | Nitric Oxide-Producing Cardiovascular Stent Coatings for Prevention of Thrombosis and Restenosis | |
| P478 | volume | 8 |
Search more.